Long BIIB

NASDAQ:BIIB1D

Biogen Inc.NASDAQ

Deskripsi

⋅ 8 Jan 2021 pukul 22.45

BIIB Daily Chart , Not a High Quality Trade!

Trading ditutup: target tercapai

⋅ 15 Jan 2021 pukul 21.26

Boooom

Trend Analysis

Komentar

Soartrader1

⋅ 9 Jan 2021 pukul 05.28

It will be a high quality trade if BIIB reruns their clinical trial on Aducanumab @10mg/kg, factors out the APO-E carriers and can show statistical improvement in cognition without adverse side effects. Will know by March if they hold an ace

Lebih lanjut